Tag Archives: Vanda

A Doggone Shame for Vanda: DC District Court Grants FDA’s Remand Motion on Dog Study/IND Clinical Hold Challenge

By Sara W. Koblitz — About 6 weeks after Vanda filed its complaint, the company’s lawsuit has joined its clinical trial: on hold.  Last week, the District Court of D.C. granted FDA’s motion for a voluntary remand of the case … Continue reading

Posted in Products Liability | Tagged , , , , , , , , , , , , | Leave a comment

Vanda Has A Bone to Pick with FDA: Dog Studies

By Sara W. Koblitz & David C. Gibbons & Deborah L. Livornese — As avowed dog-lovers and FDA law enthusiasts, a recent Complaint filed in the District Court of D.C. caught our attention.  Vanda Pharmaceuticals filed a Complaint on February … Continue reading

Posted in Products Liability | Tagged , , , | Leave a comment

Vanda on Rehearing: Will the Federal Circuit Defy SCOTUS?

by Dennis Crouch Vanda Pharms. Inc. v. West-Ward Pharms. Int’l Ltd., 887 F.3d 1117 (Fed. Cir. 2018) offers an example of a claim on the cusp of eligibility.  In a 2-1 decision, Vanda’s schizophrenia treatment claim was found eligible with … Continue reading

Posted in Intellectual Property | Tagged , , , , , | Leave a comment